Blog
Better Buy: Brookfield Infrastructure Partners vs. Brookfield Asset Management
Brookfield Asset Management (NYSE: BAM) and Brookfield Infrastructure Partners (NYSE: BIP) don't just share the Brookfield name. They also share a management team. However, they don't do the same
Better Buy: Roku vs. Twitter
Twitter (NYSE: TWTR) is a renowned microblogging social media platform with revenue primary from digital advertising. Streaming-media device maker Roku (NASDAQ: ROKU) also relies on digital
Could Your Next Coronavirus Stimulus Check Come From Your State?
Although most Americans have already spent their COVID-19 stimulus money on necessities, lawmakers in Washington, D.C., have been dragging their feet on negotiating a second coronavirus payment
3 Dividend Stocks That Pay You More Than Pepsi Does
If you're unhappy with your options in the stock market right now, you're not alone. Valuations appear high and many dividend yields look low. In fact, the 3% yield being offered by consumer goods
5G Wars: Verizon Strikes Back With a Generous New Credit Card
The "big three" U.S. wireless service companies are fiercely competing for your monthly wireless loyalty, especially as the industry begins to roll out 5G technology across the country.
The two main
Aurora Cannabis Is Doing Something Exceptionally Rare Right Now
When the first quarter of 2019 came to a close, the cannabis industry looked to be unstoppable. Wall Street's sales expectations for the industry were soaring, especially with Canada having
Why TJX Companies Could Be a Surprise Coronavirus Winner
TJX Companies (NYSE: TJX), the parent of TJ Maxx, Marshall's, and Home Goods, is the most valuable apparel retailer in the U.S.
The company's off-price strategy has been an overwhelming success over
Liquidating Investments During COVID-19? Don't Make This 1 Mistake
The COVID-19 crisis has spurred a full-blown recession that's left countless Americans grappling with income insecurity. If you're in a financial crunch due to the pandemic and you have investments
Better Buy: McDonald's vs. Papa John's
Choosing between consumer discretionary stocks such as McDonald's (NYSE: MCD) and Papa John's International (NASDAQ: PZZA) involves more than discerning between consumer tastes. On the surface, one
Better Marijuana Stock: Green Thumb Industries vs. OrganiGram
You could make a pretty compelling argument that Green Thumb Industries (OTC: GTBIF) ranks at the top of the list of U.S.-based cannabis operators. You could also make a similar argument that
Moderna Stock: Buy, Sell, or Hold?
While the COVID-19 pandemic has caused upheaval throughout the world, it has also served as a major catalyst for some stocks. You can definitely include Moderna (NASDAQ: MRNA) in the group. The
Marijuana Stocks Could Soar If Canopy Growth's "Magic Number" for U.S. Cannabis Legalization Is Right
Canopy Growth (NYSE: CGC) CEO David Klein has a "magic number" in mind for when the U.S. will legalize cannabis. In an interview with CNBC's Jim Cramer last week, Klein said that he expects cannabis
Should You Buy Fastly Stock Now?
Cloud computing specialist Fastly (NYSE: FSLY) is on a roll. The stock has quadrupled in value over the last quarter and continues to set new all-time highs nearly every day. Share prices doubled in
Better Buy: Illumina vs. Guardant Health
In recent years, investors have been drawn to healthcare companies focused on genetic research. This field has transformed science and medicine, and its innovations have made some investors wealthy
2 Biotech Stocks With Major Incoming Catalysts
Over the past three months, the Nasdaq Biotechnology index has risen around 41%, thanks largely to the hordes of investors turning their attention to shares of companies with potential coronavirus
1 Top-Notch Vacation Stock to Buy as the Economy Reopens
COVID-19 has done some serious damage to the economy. But some sectors, such as dine-in restaurants, travel, and tourism, have been hit exceptionally hard. Many stocks in these sectors have
Best Investment Strategies for Your 401(k) Plan
Roughly 58% of Americans say the coronavirus pandemic is having a negative effect on their retirement savings, while 72% say the crisis has made them rethink their retirement savings strategy
This Revolutionary Biotech Is Shrouded in Mystery. Is It a Buy?
Since the beginning of the year, shares of an under-the-radar biotech company called Dyadic International (NASDAQ: DYAI) have rallied more than 87%. Without a doubt, the company is a tough nut to
20% of Workers Risk Falling Dangerously Short on Retirement Income for This Reason
The money you get from Social Security won't be enough to cover your retirement expenses entirely. Those benefits will only replace about 40% of your pre-retirement income if you earn an average
Is It Time to Buy Brookfield Renewable Stock?
The COVID-19 pandemic has disrupted entire industries in ways that will change them permanently. Airlines, cruise operators, and many brick-and-mortar retailers are the obvious losers, while many
3 Stocks to Bankroll Your Retirement
When planning for retirement, many investors stock their portfolio with companies that offer a growing and generous dividend yield, but whose growth prospects fall somewhere between slim and none at
3 Top Stocks Millennial Investors Should Be Buying
Whether you're a tenured investor or relatively new to the investment world, this has been a head-scratcher of a year. In roughly a four-month span, the benchmark S&P 500 has crammed in about 10
I'm Not Factoring in Social Security When Figuring Out My Retirement Goals. Here's Why
When you're figuring out your retirement savings goals, one of the key steps is to think about how much income you'll need in retirement and where it will come from.
For most people, retirement
The Best Stocks to Invest in If You Have $3,000
For more than four months, investors have been taken on one heck of a roller-coaster ride. In a span of less than five weeks between February 19 and March 23, the broad-based S&P 500 entered bear
AstraZeneca COVID-19 Vaccine Shows Promise in 2-Dose Animal Trial
The results of a clinical trial in pigs administered AstraZeneca's (NYSE: AZN) COVID-19 vaccine indicate that two doses of it could be effective in treating the disease. On Tuesday, the Pirbright


